HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef.
about
Vpu Protein: The Viroporin Encoded by HIV-1Origin and diversity of human retrovirusesImpacts of humanized mouse models on the investigation of HIV-1 infection: illuminating the roles of viral accessory proteins in vivoEvolutionary conflicts between viruses and restriction factors shape immunityFactors determining human-to-human transmissibility of zoonotic pathogens via contactCounteraction of the multifunctional restriction factor tetherinVpu and BST2: Still Not There Yet?Pandemic HIV-1 Vpu overcomes intrinsic herd immunity mediated by tetherin.Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance.Efficient Vpu-Mediated Tetherin Antagonism by an HIV-1 Group O Strain.Efficient SIVcpz replication in human lymphoid tissue requires viral matrix protein adaptationReacquisition of Nef-mediated tetherin antagonism in a single in vivo passage of HIV-1 through its original chimpanzee hostHuman tetherin exerts strong selection pressure on the HIV-1 group N Vpu protein.The transmembrane domain of HIV-1 Vpu is sufficient to confer anti-tetherin activity to SIVcpz and SIVgor Vpu proteins: cytoplasmic determinants of Vpu functionNon-M variants of human immunodeficiency virus type 1.Tetherin can restrict cell-free and cell-cell transmission of HIV from primary macrophages to T cells.Simian-Human immunodeficiency viruses expressing chimeric subtype B/C Vpu proteins demonstrate the importance of the amino terminal and transmembrane domains in the rate of CD4(+) T cell loss in macaques.Nef proteins of epidemic HIV-1 group O strains antagonize human tetherin.A rare missense variant abrogates the signaling activity of tetherin/BST-2 without affecting its effect on virus releaseInvolvement of a C-terminal motif in the interference of primate lentiviral Vpu proteins with CD1d-mediated antigen presentation.HIV Vpu Interferes with NF-κB Activity but Not with Interferon Regulatory Factor 3.HIV-1 Vpu interference with innate cell-mediated immune mechanisms.Mucosal stromal fibroblasts markedly enhance HIV infection of CD4+ T cells.Construction of a high titer infectious HIV-1 subtype C proviral clone from South Africa.A comparative mutational analysis of HIV-1 Vpu subtypes B and C for the identification of determinants required to counteract BST-2/Tetherin and enhance viral egress.Preservation of tetherin and CD4 counter-activities in circulating Vpu alleles despite extensive sequence variation within HIV-1 infected individuals.The origin and molecular epidemiology of HIV.Enhanced production of enveloped viruses in BST-2-deficient cell lines.Various plus unique: Viral protein U as a plurifunctional protein for HIV-1 replicationIon Channel Activity of Vpu Proteins Is Conserved throughout Evolution of HIV-1 and SIV.The Potency of Nef-Mediated SERINC5 Antagonism Correlates with the Prevalence of Primate Lentiviruses in the Wild.HIV-1 Vpu mediated downregulation of CD155 requires alanine residues 10, 14 and 18 of the transmembrane domainHighlights, predictions, and changes.The KT Jeang Retrovirology prize 2016: Frank Kirchhoff.Inhibiting the Ins and Outs of HIV Replication: Cell-Intrinsic Antiretroviral Restrictions at the Plasma Membrane.Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2
P2860
Q26801489-344FFF97-10B0-41C6-A2E8-BABBDC23CA4BQ26849291-223DD72A-0E72-4838-8D58-F10DC0C74E16Q26851152-A0235A57-56A8-4B04-837F-F5595847F5DAQ27022032-1B21163D-BF4E-4683-81C5-7026588A3B95Q28073931-3137FD00-584F-4D44-8204-0FAE4CD5989CQ28659945-212526DC-00AD-4B76-B3A8-6845C08E1E98Q28730708-BE063ECB-6F8E-493B-8CED-7C6BD39D838CQ30376824-18C7E147-6003-4C31-9E2E-EE83401A2E7FQ30391895-EB83D5B0-2744-4A3C-80AA-699CB2D18676Q30397332-DC9D91A9-C54C-434A-A59E-B87143AD44E5Q30415403-CAD91ABE-42D5-4204-A527-78E18F99A25BQ30421288-DD0FE5FE-DC83-42D6-9D15-0AC9A3FFDF95Q30425799-4DEB677A-0F0C-4A6D-9E21-4FD3F3EB2701Q30428532-857A7034-0F56-4EFC-A060-30EC36A800B9Q30432689-CBF679A6-3E83-4127-909C-1AC22CC07B2AQ31172123-0EB71B8A-16E6-4E72-A237-25081EB5172DQ33926191-7F206A31-CF61-4A79-86D1-0A5FCE29CD3CQ34761549-EDF30075-69FC-4441-9FC7-434B9904B309Q34929498-D7721724-BF91-4E7D-8E35-59D4D3BD5636Q35424048-F02AB527-8BCE-4A20-8378-93CC8AA9CCD7Q36080904-4FE19D5F-ACA0-4A49-987C-C0F90346016DQ36141355-08653B2E-D469-4C17-B921-DA56D70411D7Q36283017-03EFDABA-2823-461A-B888-A245700376FCQ36404211-63CC7299-D9FE-40F9-8D89-50ABD49DFF46Q37141248-750252A4-CEB6-498D-B294-4802A592A401Q37510562-0538EF21-3C18-4C60-9932-E1989F1FFC2BQ38134898-8DFF6089-D201-4083-AD0A-4BB8CA885ADAQ38703697-7D47BA2E-CE58-4434-A973-44B7C5492005Q38739273-D6885B39-BBA9-4E6E-A5AD-53F159C1EB5EQ40042729-B8B7A46D-6934-48D6-9B0A-77A37FD0B207Q40580241-57D122C4-CA03-469F-8178-B0172F0C6971Q42031796-A9605F89-FA0A-4FD9-B871-4C15463E7203Q42374102-23DE708E-2AAC-4C5C-9013-8109468385CFQ42379656-FE3A5631-621C-423D-AE0D-C4640EB42584Q47550785-BC960AD7-6069-47E5-8CAF-08E89FCC668BQ57093831-88D03CFD-F018-426B-881D-6F3D9E937453
P2860
HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef.
@ast
HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef.
@en
type
label
HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef.
@ast
HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef.
@en
prefLabel
HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef.
@ast
HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef.
@en
P2093
P2860
P50
P356
P1433
P1476
HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef.
@en
P2093
Daniel Sauter
Greg J Towers
Ravindra K Gupta
Sarah J Petit
P2860
P2888
P356
10.1186/1742-4690-8-103
P577
2011-12-15T00:00:00Z
P5875
P6179
1014890304